ANI PHARMACEUTICALS, INC — Operating Income by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/214a119b-6025-436b-b082-799e20a901e1/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $111.1M | 2025-01-01 – 2025-12-31 | evidence 0001023024-26-000014 |
| FY 2024 | $584.0k | 2024-01-01 – 2024-12-31 | evidence 0001023024-25-000015 |
| FY 2023 | $47.0M | 2023-01-01 – 2023-12-31 | evidence 0001023024-24-000026 |
| FY 2022 | $-35.3M | 2022-01-01 – 2022-12-31 | evidence 0001023024-23-000005 |
| FY 2021 | $-39.8M | 2021-01-01 – 2021-12-31 | evidence 0001023024-22-000004 |
| FY 2020 | $-16.0M | 2020-01-01 – 2020-12-31 | evidence 0001023024-21-000007 |
| FY 2019 | $16.4M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-025744 |
| FY 2018 | $35.4M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-010541 |
| FY 2017 | $28.3M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-011197 |
| FY 2016 | $20.1M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-012507 |
| FY 2015 | $32.7M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-083848 |
| FY 2014 | $20.0M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-011270 |
| FY 2013 | $898.0k | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-012277 |
| FY 2012 | $-42.0k | 2012-01-01 – 2012-12-31 | evidence 0001144204-14-012277 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).